The heterogeneity and evolutionary flexibility of cancer cells has largely rendered monotherapy of cancer with single targeted agents futile. To address this challenge, molecular multi-targeting has emerged as a key concept in cancer care. Two distinct approaches to molecular multitargeting can be pursued.

Read more